euthyrox 50 mikrogram tabletter
merck a/s - levothyroxinnatrium - tabletter - 50 mikrogram
marvelon 150+30 mikrogram tabletter
merck sharp & dohme b.v. - desogestrel, ethinylestradiol - tabletter - 150+30 mikrogram
pregnyl 1500 ie pulver og solvens til injektionsvæske, opløsning
merck sharp & dohme b.v. - choriongonadotropin - pulver og solvens til injektionsvæske, opløsning - 1500 ie
pregnyl 5000 ie pulver og solvens til injektionsvæske, opløsning
merck sharp & dohme b.v. - choriongonadotropin - pulver og solvens til injektionsvæske, opløsning - 5000 ie
sinemet depot 50+200 mg depottabletter
merck sharp & dohme b.v. - carbidopamonohydrat, levodopa - depottabletter - 50+200 mg
singulair 4 mg granulat
merck sharp & dohme b.v. - montelukastnatrium - granulat - 4 mg
zocor 20 mg filmovertrukne tabletter
merck sharp & dohme b.v. - simvastatin - filmovertrukne tabletter - 20 mg
bavencio
merck europe b.v. - avelumab - neuroendocrine tumorer - andre antineoplastiske midler, monoklonale antistoffer - bavencio er indiceret som monoterapi til behandling af voksne patienter med metastatisk merkel cellecarcinom (mcc). bavencio i kombination med axitinib er angivet for den første linje behandling af voksne patienter med fremskredent renalcellecarcinom (rcc). bavencio is indicated as monotherapy for the first‑line maintenance treatment of adult patients with locally advanced or metastatic urothelial carcinoma (uc) who are progression-free following platinum‑based chemotherapy.
mavenclad
merck europe b.v. - cladribine - multipel sclerose - immunosuppressiva - behandling af voksne patienter med højt aktiv recidiverende multipel sklerose (ms) som defineret ved kliniske eller billeddannende egenskaber.
segluromet
merck sharp & dohme b.v. - ertugliflozin l-pyroglutamic acid, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - segluromet is indicated in adults aged 18 years and older with type 2 diabetes mellitus as an adjunct to diet and exercise to improve glycaemic control:in patients not adequately controlled on their maximally tolerated dose of metformin alonein patients on their maximally tolerated doses of metformin in addition to other medicinal products for the treatment of diabetesin patients already being treated with the combination of ertugliflozin and metformin as separate tablets.